(NASDAQ: ANGO) Angiodynamics's forecast annual revenue growth rate of 4.42% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.23%.
Angiodynamics's revenue in 2026 is $313,725,000.On average, 6 Wall Street analysts forecast ANGO's revenue for 2026 to be $13,234,448,475, with the lowest ANGO revenue forecast at $12,694,410,255, and the highest ANGO revenue forecast at $13,648,877,192. On average, 6 Wall Street analysts forecast ANGO's revenue for 2027 to be $13,891,006,034, with the lowest ANGO revenue forecast at $13,257,173,878, and the highest ANGO revenue forecast at $14,360,388,908.
In 2028, ANGO is forecast to generate $14,842,167,457 in revenue, with the lowest revenue forecast at $14,259,983,945 and the highest revenue forecast at $15,278,908,389.